Reuters logo
18 days ago
BRIEF-Jubilant Life Sciences gets ANDA nod for generic drug to treat depression
July 6, 2017 / 5:37 AM / 18 days ago

BRIEF-Jubilant Life Sciences gets ANDA nod for generic drug to treat depression

1 Min Read

July 6 (Reuters) - Jubilant Life Sciences Ltd:

* Says Jubilant receives ANDA approval for bupropion hydrochloride extended-release tablets

* Says drug intended for treatment of major depressive disorder and prevention of seasonal affective disorder Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below